Lisle M. Nabell
- Medicare services, 2024
- 2,859
- Medicare patients, 2024
- 612
- Part D claims, 2024
- 1,132
- Publications
- 49
- Clinical trials
- 14
- Practice address
- 619 19th S St, Birmingham, AL 35211
- Practice phone
- Call (205) 731-9770
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
University of Alabama Birmingham Hospital
Birmingham, Alabama
Find Lisle Nabell's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Lisle M. Nabell is a hematologist and oncologist in Birmingham, Alabama
Lisle Nabell practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.
Lisle Nabell's NPI, 1700810009, was assigned on July 10, 2006. Lisle Nabell graduated from University of North Carolina School of Medicine in 1987. Lisle Nabell's Alabama license number on file is 14404.
- NPI
- 1700810009NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6204008477
- NPI enumeration date
- July 10, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (205) 731-9770
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 65
- Medical school graduation
- 1987
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Lisle M. Nabell practices at University of Alabama Birmingham Hospital in Birmingham, Alabama
Lisle Nabell's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.
- University of Alabama Birmingham Hospital619 19th S St, Birmingham, AL 35211 · Jefferson CountyPhone(205) 731-9770
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Lisle M. Nabell is affiliated with 2 sites of care and 1 medical group
Lisle Nabell's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Lisle Nabell is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Lisle M. Nabell's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Lisle Nabell practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| University of Alabama Birmingham Hospital | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Lisle M. Nabell is one of 169 hematologists and oncologists in Alabama
Hematology and oncology is Lisle Nabell's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Lisle Nabell is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Lisle Nabell's licenses on file in 2 states: Alabama and North Carolina.
Specialties and state licenses
- Hematology and oncology, AlabamaPrimary
- North Carolina license
Clinical focus
Dmand AI lists breast cancer, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Lisle Nabell treats.
Hematologists and oncologists near Lisle Nabell
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Lisle M. Nabell billed Medicare for 2,859 services in 2024
CMS data shows 2,859 Medicare services from Lisle Nabell across 6 procedure codes in 2024, for 612 Medicare patients. Medicare paid $199,612 for them.
Lisle Nabell's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Other services
- 2023: 1,1332024: 2,487120%
- Office and hospital visits
- 2023: 4122024: 37210%
Where Lisle Nabell's Medicare services took place, 2024
- In an office2338%
- In a facility2,62692%
Lisle Nabell compared with the Alabama median for hematologists and oncologists, 2024
- Lisle Nabell
- Alabama median
- Medicare services
- 2,859vs 1,2242.3 times
- Medicare patients
- 612vs 2822.2 times
- Part D claims
- 846vs 846Close to median
Medians across 162 hematologists and oncologists in Alabama with Dmand AI profiles that report each measure.
Lisle Nabell's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Lisle Nabell?
Medicare shows one payer. Book a meeting to get commercial claims data for Lisle Nabell and other hematologists and oncologists in Alabama.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Lisle M. Nabell treated 612 Medicare patients in 2024, average age 72
CMS counts 612 Medicare patients who saw Lisle Nabell in 2024. The largest group is 65 to 74, with 276 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Lisle Nabell's median patient age at 67, with 51% women.
Lisle Nabell's Medicare patients by age, 2024
Lisle Nabell's Medicare patients by sex, 2024
- Women29248%
- Men32052%
Chronic conditions among Lisle Nabell's Medicare patients, 2024
- High blood pressure75%
- High cholesterol69%
- Cancer58%
- Arthritis46%
- Anxiety29%
- Ischemic heart disease29%
- Chronic kidney disease28%
- Diabetes27%
Share of Medicare patients with each condition. A patient can have several.
Lisle Nabell's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women51%
- Men49%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Lisle M. Nabell wrote 1,132 Medicare Part D claims in 2024
In 2024, Lisle Nabell wrote 1,132 Medicare Part D claims for 214 patients. 84% of them were for generic drugs. CMS names the drug for 846 of them, across 26 drugs with 11 or more claims each, at $993,687 in total drug cost. In 2023, CMS named 1,181 claims across 36 drugs.
Lisle Nabell's Part D claims by kind of drug, 2024
- Generic948 claims84%
- Brand-name184 claims16%
Lisle Nabell's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Lisle Nabell's Part D claims, 2024
- Opioids19%216 of 1,132 claims
- Antibiotics2%17 of 1,132 claims
- Antipsychotics, patients 65 and over3%32 of 1,132 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,1812024: 84628%
Drugs named by CMS: 26 in 2024, 36 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Lisle M. Nabell takes part in Medicare
Lisle Nabell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Lisle M. Nabell has 49 publications on record
Dmand AI links 49 papers to Lisle Nabell, published from 2008 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Head and Neck Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Antineoplastic Agents. Lisle Nabell has published most often in Clin Cancer Res. Lisle Nabell's most frequent co-authors are William R. Carroll, MD, Sharon Ann Spencer and Jimmy Caudell, MD.
Lisle Nabell's papers by year, 2016 to 2025
Topics Lisle Nabell writes about most
- Head and Neck Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents
- Breast Neoplasms
- Carcinoma, Squamous Cell
- Squamous Cell Carcinoma of Head and Neck
- Antibodies, Monoclonal, Humanized
- Cetuximab
Lisle Nabell's most frequent co-authors
- William R. Carroll, MD12 shared papers
- Sharon Ann Spencer7 shared papers
- Jimmy Caudell, MD4 shared papers
Recent publications by Lisle Nabell
See who Lisle Nabell researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Lisle Nabell works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Lisle M. Nabell has worked on 14 clinical trials
Dmand AI links Lisle Nabell to 14 clinical trials, 8 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck and Carcinoma, Squamous Cell. University of Alabama at Birmingham sponsors the most, 5.
Clinical trials with Lisle Nabell by phase
- 2Phase 1: 2 trials
- 3Phase 1/2: 3 trials
- 8Phase 2: 8 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Lisle Nabell's trials
- Head and Neck Neoplasms
- Squamous Cell Carcinoma of Head and Neck
- Carcinoma, Squamous Cell
- Brain Neoplasms
- Breast Neoplasms
Investigators on the most trials with Lisle Nabell
- Guru P. Sonpavde, MD3 shared trials
- Douglas Earl Laux, MD2 shared trials
- Vandana Gupta Abramson, MD1 shared trial
Recent clinical trials with Lisle Nabell
Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Lisle M. Nabell received $3,364 in industry payments from 2016 to 2025
CMS Open Payments shows 8 general payments to Lisle Nabell from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 90% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $2,620. It also lists 1 research payment totaling $330 in 2025.
General payments to Lisle Nabell by program year, 2016 to 2025
General payments to Lisle Nabell by kind, 2016 to 2025
- Consulting fees$3,04190%
- Education$1936%
- Food and beverage$1304%
Companies that paid Lisle Nabell the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Lisle M. Nabell has 4 awards and honors on record
Dmand AI lists 4 awards for Lisle Nabell, most recently America's Top Doctors in 2014.
Awards and honors for Lisle Nabell
- 2014
- America's Top Doctors
- 2013
- America's Top Doctors for Cancer
- 2012
- CMS Stage 1 2012
- Undated
- Checkbook Top Doc
Source: Dmand AI Professional Profile Data
Lisle M. Nabell graduated from University of North Carolina School of Medicine
Lisle Nabell graduated from University of North Carolina School of Medicine in 1987.
- Medical school
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Lisle M. Nabell accepts plans from 10 insurance carriers
Lisle Nabell is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.
- Aetna
- Elevance
- Blue Cross Blue Shield of Michigan
- Cigna
- Blue Cross Blue Shield of Massachusetts
- HCSC
- Humana
- Regence Health Plans
- +2 more carriersWith a free account
Plan types Lisle Nabell accepts, by number of carriers
- Medicare9
- PPO8
- EPO3
- HMO3
- POS3
Source: Dmand AI Insurance Network Data
Sources for Lisle M. Nabell's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Lisle M. Nabell
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Lisle M. Nabell's NPI number?
Lisle M. Nabell's NPI number is 1700810009. It was assigned on July 10, 2006, and it is active in the NPI Registry.
What does Lisle M. Nabell specialize in?
Lisle M. Nabell is a hematologist and oncologist in Birmingham, Alabama. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Lisle M. Nabell practice?
Lisle Nabell practices at 619 19th S St, Birmingham, AL 35211. Lisle Nabell's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama.
What is Lisle M. Nabell's office phone number?
The practice phone on file for Lisle Nabell is (205) 731-9770.
What is Lisle M. Nabell's medical license number?
Lisle Nabell's Alabama license number on file is 14404, one of the licenses on file in 2 states.
Which states has Lisle M. Nabell been licensed in?
Dmand AI has state licenses on file for Lisle Nabell in Alabama (1988 to 2025) and North Carolina (1988 to 1990).
Which hospitals is Lisle M. Nabell affiliated with?
Lisle Nabell is affiliated with UAB Hospital.
What medical group is Lisle M. Nabell part of?
Lisle Nabell is linked to UAB Medicine.
Does Lisle M. Nabell accept Medicare?
Yes. CMS data shows Lisle Nabell billed Medicare for 2,859 services in 2024, and Lisle Nabell accepts Medicare assignment.
How many Medicare patients does Lisle M. Nabell see?
CMS counts 612 Medicare patients who saw Lisle Nabell in 2024, with an average age of 72.
Show 9 more questionsShow fewer questions
Is Lisle M. Nabell board certified?
Yes. Lisle Nabell is board certified in medical oncology by the American Board of Internal Medicine.
What services does Lisle M. Nabell bill to Medicare?
In 2024, Lisle Nabell's most billed Medicare services were quality measure (M0010), medicare service (G2211) and office visit, established patient (99214).
Where did Lisle M. Nabell go to medical school?
Lisle Nabell graduated from University of North Carolina School of Medicine in 1987.
What drugs does Lisle M. Nabell prescribe most?
In 2024 Medicare Part D data, Lisle Nabell's most prescribed drugs by claims were Anastrozole, Oxycodone HCl and Ondansetron HCl.
Has Lisle M. Nabell received payments from drug or device companies?
CMS Open Payments shows $3,364 in general payments to Lisle Nabell from 6 companies from 2016 to 2025. The largest total came from Regeneron Pharmaceuticals, Inc.
How long has Lisle M. Nabell been practicing?
Lisle Nabell graduated from medical school in 1987, 39 years ago.
Does Lisle M. Nabell do research?
Dmand AI links 49 publications to Lisle Nabell, published from 2008 to 2025. Lisle Nabell has worked on 14 clinical trials.
Who does Lisle M. Nabell publish with?
Lisle Nabell's most frequent co-authors are William R. Carroll, MD (12 shared papers), Sharon Ann Spencer (7 shared papers) and Jimmy Caudell, MD (4 shared papers).
What insurance does Lisle M. Nabell accept?
Lisle Nabell is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in Alabama by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card